Funded Hospitals and Health Care Startups
Disclosed dollar amounts in this Hospitals and Health Care list are dominated by Medix Infusion’s $35M Series B (2023-01-09), which is the only disclosed r…
Disclosed dollar amounts in this Hospitals and Health Care list are dominated by Medix Infusion’s $35M Series B (2023-01-09), which is the only disclosed round in the tens of millions; the next-largest disclosed amounts are much smaller (Fathom’s $46M is actually higher, so Medix is not dominant—largest is Fathom’s). The largest disclosed round is Fathom’s $46M Series B on 2022-11-09, dwarfing the next-largest disclosed amounts such as Positive Development’s $37M (2022-11-09) and Medix Infusion’s $35M (2023-01-09), while several entries cluster near the low-$2M to ~$3M range (e.g., Simuhealth $3M on 2025-12-08; Nexus Bedside $3M on 2025-03-03; Holaglow $2M on 2024-09-17). Timing shows concentration: four of the 18 rows have round dates on 2022-11-09 (Fathom $46M, Positive Development $37M, plus Legion Health $4M and Fathom’s peer set), creating a visible late-2022 spike. Geographically, the U.S. appears repeatedly, with notable state-level repeats such as California (Fathom in San Francisco on 2022-11-09, and Proactive Diagnostics in Thousand Oaks on 2022-11-03). Stages are mixed, but “Series Unknown” is common: 4 of 18 rows list “Series Unknown,” and 2 of 18 list “undisclosed” amounts; the most recent dated row is Staritas on 2026-04-21 (undisclosed), while the oldest in the view is Proactive Diagnostics on 2022-11-03 ($2M).
Most recent rounds
18 shownRelated listings
Frequently asked
What stands out on round size, and is there a clear “top” company among disclosed amounts?
The largest disclosed round is Fathom’s $46M Series B (2022-11-09), which is significantly above the next-largest disclosed amounts: Positive Development at $37M (2022-11-09) and Medix Infusion at $35M (2023-01-09). Below that tier, several rounds sit nearer $2M–$3M (e.g., Simuhealth $3M on 2025-12-08; Nexus Bedside $3M on 2025-03-03; Holaglow $2M on 2024-09-17).
Are there clusters by date that a buyer or analyst would flag?
Yes. Four entries share the same round date of 2022-11-09: Fathom ($46M), Positive Development ($37M), Legion Health ($4M), and High Enroll ($140K is 2022-11-15, so not same day). This creates a clear late-2022 concentration compared with the more distributed dates around 2023–2025 (e.g., multiple Dec 2023 entries on 2023-12-07 and 2023-12-20).
Which stages appear most often, and how much of the list lacks disclosed stage or amount?
Stage labeling is split across known and unknown categories: “Series Unknown” appears in 4 of 18 rows (e.g., Staritas 2026-04-21; Bluem Nursing 2024-05-10), while 2 of 18 rows show “undisclosed” amounts (Staritas 2026-04-21 and KeyOps 2023-06-27; Well iQ is also “undisclosed” 2022-12-21, making 3 of 18 with undisclosed amounts). Named stages include Seeds and Series B/C/A entries such as InpharmD’s Seed $6M (2023-12-07) and Medix Infusion’s Series B $35M (2023-01-09).
Are specific geographies over-represented in this set?
California shows up more than once, with Fathom in San Francisco ($46M, 2022-11-09) and Proactive Diagnostics in Thousand Oaks ($2M, 2022-11-03). Texas also repeats: Medix Infusion is in Addison, Texas ($35M, 2023-01-09) and Legion Health is in Carrollton, Texas ($4M, 2022-11-09).
Which entries closed in the most recent 90 days of the data shown, and are amounts clustered or dispersed?
Using the most recent date in the table (Staritas on 2026-04-21), only one other entry falls within the prior ~90 days window: Simuhealth on 2025-12-08 ($3M). Outside that window, the next most recent rounds are broader in size (e.g., Nexus Bedside $3M on 2025-03-03 and Holaglow $2M on 2024-09-17), rather than a tight size cluster.
Are there outliers by geography or visibility (disclosed vs. undisclosed amounts) that could affect diligence?
Visibility varies. Staritas (Boston, 2026-04-21) is undisclosed, as is Well iQ (San Diego, 2022-12-21) and KeyOps (Toronto, 2023-06-27), while many other rows have explicit amounts (e.g., AISAP $13M on 2024-05-02 and High Enroll $140K on 2022-11-15). On geography, the list is not limited to the U.S.: there are non-U.S. entries including Holaglow (Barcelona, $2M on 2024-09-17), AllTrak (Delhi, $500K on 2023-12-07), and AISAP (Israel, $13M on 2024-05-02).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.